Grasim shares in focus after Q2 PAT declines 66% YoY
Shares of Grasim Industries will be in focus in Monday’s trade after the company reported a 66% fall in its consolidated net profit at Rs 389 crore in the second …
Shares of Grasim Industries will be in focus in Monday’s trade after the company reported a 66% fall in its consolidated net profit at Rs 389 crore in the second …
The second quarter earnings season is underway and as many as 114 companies will announce their quarterly numbers for the July-September 2024 period today. Key results to watch out include …
Arnab Banerjee, MD & CEO, Ceat, says price hikes will continue because the pass-through to the tyres per se is inadequate if cumulative price hikes from April to August are …
HSBC initiated coverage on Krishna Institute of Medical Sciences (KIMS) with a ‘buy’ rating while assigning ‘reduce’ rating to Global Health (Medanta) and Narayana Hrudayalaya. The brokerage has a ‘buy’ …
“In North America, Revlimid is the key contributor and again, speciality drugs for Zydus Lifesciences that will keep on increasing EBITDA margins towards 29-30% and also in the valuation-wise Zydus …
Shares of Honasa Consumer, which owns Mamearth, rallied 7% in Friday’s session on BSE to the day’s high of Rs 447.70 after reporting a net profit of Rs 30.4 crore …
Vishal Thakkar, Deputy CFO and Gopal Agrawal, CEO, Anupam Rasayan, in conversation with ET Now. Agrawal says: “Even in FY24, our EBITDA margins have been steady and that is precisely …
The TVS Motor stock is trading at 35 times its one-year forward earnings, compared with the long-term average of 28 times. Synopsis A better product mix and a judicious call …
Divi’s Laboratories. Share Price 4028.20 10:09 AM | 02 Jan 2024 112.10(2.86%) Cipla. Share Price 1271.70 10:09 AM | 02 Jan 2024 20.71(1.65%) Sun Pharmaceutical Industries. Share Price 1281.00 10:09 …